The reason anyone gets insanely rich is almost always because of the stock market. It certainly how @elonmusk did.
— Mark Cuban (@mcuban) June 13, 2026
And the reason they get rich from the stock market, is because 150m Americans decided they wanted to own shares of stocks directly, or through their retirement… https://t.co/Xk1LnI1EiY
Mark Cuban on U.S. Healthcare: The Problem of Opaque Conglomerates and the Power of Transparency and Direct Contracting https://t.co/VpzY78JJT1
— Paramendra Kumar Bhagat (@paramendra) June 13, 2026
Can Single Payer Be Made To Work?
Mark Cuban on U.S. Healthcare: The Problem of Opaque Conglomerates and the Power of Transparency and Direct Contracting.
In a recent tweet responding to a critique of capitalism versus socialism, Mark Cuban defended market-driven wealth creation while pivoting to one of his signature issues: reforming U.S. healthcare. He argued that the core issue isn't billionaires or capitalism itself, but "behemoth HC conglomerates" that drive up costs and reduce access and quality. Cuban urged large employers and innovators like Elon Musk to bypass these entities by contracting directly with transparently priced providers.
Cuban's views, drawn from his tweets, his ventures like Cost Plus Drugs and Cost Plus Wellness, and public statements, center on a consistent diagnosis: the U.S. healthcare system is a simple industry made artificially complex and expensive by layers of intermediaries—primarily vertically integrated insurance companies, pharmacy benefit managers (PBMs), and large hospital systems—that prioritize margins over value, transparency, or outcomes. The Problem: Middlemen, Opacity, and Misaligned IncentivesCuban identifies vertically integrated healthcare conglomerates as the primary culprits. These entities often combine insurance, PBMs, pharmacies, and other services, creating massive information asymmetry. Employers (who fund much of private insurance) don't know the true price of care or what their insurers actually pay providers. Patients face deductibles, copays, coinsurance, and surprise bills without meaningful ability to shop or understand costs.
Key issues he highlights include:
- Spread pricing and hidden fees: Insurers and PBMs add layers of profit (spreads, rebates, administrative fees, broker fees) that act as a "tax" on employers and patients. Contracts often include nondisclosure agreements that keep pricing opaque.
- Lack of price shopping and perverse incentives: Once patients hit deductibles or out-of-pocket maximums, there's little incentive for them to seek lower costs—and providers may raise prices knowing this. Employers and patients lack data on deductible yield or true costs.
- PBM dominance: These control formularies (which drugs are covered), limiting competition and enabling extortionate practices against independent pharmacies (post-payment audits, fees for switches/hubs they control, delayed payments). Cuban notes there is "no competition, except to be on the PBM formulary."
- No market discipline: Big conglomerates face little competitive pressure to lower costs or improve service. Cuban questions whether the market has ever meaningfully disciplined them.
- Broader systemic drag: High costs reduce wages, bankrupt families, and divert resources. Cuban has critiqued both status-quo employer-sponsored insurance and single-payer proposals like Medicare for All, arguing the latter wouldn't fix underlying cost opacity and intermediary power without major structural changes.
Cuban is not anti-hospital or anti-provider; he acknowledges their challenges (e.g., debt, cost accounting issues) but sees conglomerates as extracting value from all sides—patients, employers, providers, and pharmacies. The Solutions: Transparency, Direct Contracting, and Breaking Up ConglomeratesCuban's proposed fixes emphasize market-oriented disruption through radical transparency and removing intermediaries:
- Direct Contracting: Self-insured employers should bypass big insurers/PBMs and contract directly with providers and pharmacies. This can lower total costs dramatically (enough to eliminate employee out-of-pocket costs in many cases) while allowing providers to earn more by cutting out the middle. Cuban promotes tools like Cost Plus Wellness for this.
- Price Transparency and Fixed Markups: Cost Plus Drugs sells generics at transparent cost-plus-15% (plus flat shipping), bypassing traditional markups and rebates. This has driven massive savings (often 50-90% on generics) and pressured the market. Extend this logic to care via public contracts.
- Pass-Through Models and Competition: Use independent, transparent PBMs or alternatives. Support cash-pay options that count toward deductibles. Encourage provider networks with published contracts.
- Break Up Big Medicine: Cuban supports legislation like the Break Up Big Medicine Act (bipartisan, from Sens. Warren and Hawley) to separate insurance from PBM ownership and curb vertical integration. He argues this is essential for any meaningful reform, including universal coverage goals.
- Other Ideas: Negotiate better (providers get more, employers pay less); leverage data and AI/LLMs to spot overcharges; make medical education more accessible long-term; focus on outcomes over volume.
- Employers lead: As major payers (especially self-insured ones), they can demand transparency, switch to direct models, and use platforms like Cost Plus. Collective action by hundreds of companies could reshape the market quickly.
- Entrepreneurial disruption: Cuban’s own companies demonstrate it works. Transparency + fair margins erodes incumbent power without needing perfect policy.
- Policy support: Antitrust action to break conglomerates, state-level reforms on formularies or cash pricing, and removing barriers to direct contracting.
- Cultural shift: Large buyers (corporations, governments) stop rewarding opacity. Patients and advocates push for data and options.
A "Mark Cuban Healthcare Reform Act" would not look like Medicare for All, nor would it preserve the current insurance-centric system. It would seek to create a transparent healthcare marketplace where employers, patients, providers, and pharmacies can transact directly while eliminating the market power of vertically integrated intermediaries. (Democracy Forum)
The Healthcare Transparency and Competition Act of 2027
Title I: Break Up Vertical Healthcare Monopolies
Section 101: Prohibition on Vertical Integration
No company may simultaneously own:
A health insurance company
A PBM (Pharmacy Benefit Manager)
A retail pharmacy chain
A specialty pharmacy
A physician practice network
A hospital system
Companies would have 5 years to divest conflicting assets.
Section 102: Antitrust Review
The Federal Trade Commission and Department of Justice shall review all healthcare mergers above $100 million.
Section 103: Ban Anti-Competitive Contracting
Prohibit:
Most-favored-nation clauses
Gag clauses
Exclusive PBM arrangements
Anti-steering provisions
Title II: Radical Price Transparency
Section 201: Public Healthcare Pricing Database
Every provider must publish:
Cash price
Negotiated insurer price
Medicare reimbursement rate
Average total episode cost
Prices must be machine-readable and searchable.
Section 202: Real-Time Cost Disclosure
Before non-emergency treatment:
Patients receive:
Total expected cost
Provider reimbursement
Facility fees
Drug costs
Alternative provider options nearby
Section 203: National Healthcare Price Exchange
A federally operated marketplace displaying:
All provider prices
Quality metrics
Outcomes
Wait times
Comparable to airline fare search engines.
Title III: PBM Reform
Section 301: Ban Spread Pricing
PBMs must operate on a pass-through basis.
Any amount paid by employers must be transmitted directly to providers and pharmacies.
Section 302: Rebate Elimination
Manufacturer rebates prohibited.
Drug discounts must be reflected directly in patient prices.
Section 303: Open Formularies
PBMs may not exclude lower-cost therapeutically equivalent drugs without documented clinical justification.
Section 304: Pharmacy Fairness
Ban:
Retroactive clawbacks
DIR fees
Delayed reimbursement schemes
Predatory audit practices
Title IV: Direct Employer Contracting
Section 401: Employer Freedom Act
Any self-insured employer may directly contract with:
Hospitals
Physician groups
Pharmacies
Surgery centers
Telemedicine providers
without intermediary approval.
Section 402: Safe Harbor Protections
Employers using direct contracting receive:
ERISA liability protections
Standardized federal contracting templates
Reduced reporting burdens
Section 403: National Direct Contracting Exchange
A federal digital marketplace where employers can:
Compare providers
Negotiate contracts
Purchase bundled care
Title V: Transparent Drug Markets
Section 501: Cost-Plus Pharmacy Model
Pharmacies may voluntarily register as:
"Certified Transparent Pharmacies."
Requirements:
Acquisition cost disclosure
Fixed markup disclosure
No hidden rebates
Section 502: National Generic Drug Marketplace
Patients may compare generic drug prices nationwide.
Section 503: Deductible Reform
Cash-pay prescriptions count toward:
Deductibles
Out-of-pocket maximums
Health savings accounts
This removes the penalty for shopping outside insurer networks.
Title VI: Bundled Care and Outcomes
Section 601: Episode-Based Pricing
Providers encouraged to offer fixed prices for:
Knee replacement
Childbirth
Cancer treatment pathways
Cardiac procedures
Section 602: Warranty-Based Medicine
Providers may voluntarily offer:
Outcome guarantees
Readmission warranties
Complication warranties
Section 603: Quality Reporting
National reporting system for:
Infection rates
Readmissions
Mortality
Patient satisfaction
Title VII: Healthcare Data Rights
Section 701: Patient Ownership of Data
Patients own:
Medical records
Claims data
Prescription history
Section 702: Universal Data Portability
Records transferable instantly between providers.
Section 703: AI Transparency Tools
Government APIs allow third parties to build:
Cost comparison tools
Fraud detection tools
Medical billing analysis tools
Title VIII: Universal Catastrophic Coverage
This is where Congress could address coverage without creating a single-payer system.
Section 801: Federal Catastrophic Health Insurance
Government covers:
Costs above $25,000 per person annually
or another threshold set by Congress.
Section 802: Universal Enrollment
Every American automatically enrolled.
Section 803: Basic Protection Guarantee
No citizen may face bankruptcy from medical bills.
Title IX: Provider Expansion
Section 901: Medical School Expansion
Federal grants to double medical school capacity within ten years.
Section 902: Residency Expansion
Remove residency bottlenecks.
Section 903: Interstate Licensing
National physician licensing compact.
Section 904: Telemedicine Freedom
Nationwide telemedicine practice rights.
Title X: Sunset and Savings
Section 1001: Healthcare Cost Reduction Target
National goal:
Reduce healthcare spending from roughly 18% of GDP toward 12–14% over fifteen years.
Section 1002: Shared Savings
Employers achieving verified savings may:
Share savings with employees tax-free
Increase wages
Fund HSAs
Section 1003: Annual Congressional Review
Annual report measuring:
Healthcare inflation
Transparency compliance
Competition levels
PBM concentration
Employer savings
What Makes This "Cuban-Style"?
The bill's philosophy is simple:
Break up healthcare conglomerates.
Make every price visible.
Let employers contract directly.
Eliminate PBM rent-seeking.
Reward transparent providers.
Use competition rather than bureaucracy to lower costs.
Preserve universal protection against catastrophic expenses. (Democracy Forum)
In many ways, this approach sits between today's employer-insurance system and single-payer healthcare: it relies on markets for efficiency but uses federal rules to force transparency, competition, and universal catastrophic coverage. That is probably the closest legislative expression of the healthcare vision Mark Cuban has been advocating. (Democracy Forum)
If the goal is a true single-payer system that is both politically feasible and operationally successful, the biggest challenge is not designing the end state. Almost every developed country has demonstrated versions of single-payer, national health insurance, or heavily regulated universal coverage.
The challenge is the transition.
The United States currently spends over $4 trillion annually on healthcare, employs millions of people in insurance and healthcare administration, and ties coverage to employment for most working-age adults. A successful transition must avoid disrupting care, collapsing provider finances, or creating political backlash.
The American Health Security Act
Purpose
Guarantee healthcare as a universal right for every American while reducing overall national healthcare spending, eliminating medical bankruptcy, and simplifying administration.
Title I: Universal Coverage
Section 101: Automatic Enrollment
Every U.S. citizen and legal resident is automatically enrolled at birth or upon legal residency.
No application required.
No enrollment periods.
No eligibility tests.
No network restrictions.
Section 102: Comprehensive Benefits
Coverage includes:
Primary care
Specialty care
Hospital care
Emergency care
Mental health
Prescription drugs
Maternity care
Preventive care
Rehabilitation
Long-term care
Dental
Vision
Hearing
No lifetime limits.
No annual limits.
Section 103: No Financial Barriers
Eliminate:
Premiums
Deductibles
Coinsurance
Surprise bills
Small co-pays may remain for certain discretionary services.
Title II: Single National Health Fund
Section 201: Creation of American Health Trust
A federally administered public trust becomes the sole payer for covered services.
Private insurers no longer pay for core healthcare services.
Section 202: Funding
Funding sources:
Payroll Tax
Shared employer-employee contribution.
Progressive Income Tax Surcharge
Higher earners contribute more.
Capital Gains Contribution
Small dedicated healthcare contribution.
Existing Federal Spending
Transfer funding from:
Medicare
Medicaid
ACA subsidies
CHIP
Veterans healthcare reimbursements
into the unified fund.
Title III: Provider Payment Reform
Section 301: Global Hospital Budgets
Hospitals receive annual operating budgets.
This eliminates:
Per-procedure billing
Upcoding incentives
Revenue cycle departments
Section 302: Physician Compensation
Physicians may choose:
Fee-for-service
Salary models
Group practice contracts
within national guidelines.
Section 303: Rural Protection
Additional funding for:
Rural hospitals
Critical access facilities
Underserved regions
Title IV: Pharmaceutical Reform
Section 401: National Drug Negotiation
Government negotiates drug prices nationally.
Section 402: Reference Pricing
Drug prices benchmarked against peer nations.
Section 403: Generic Competition
Fast-track approval for generic medicines.
Title V: Administrative Simplification
Section 501: Single Claims Standard
One billing system nationwide.
Section 502: Unified Electronic Records
National interoperability requirements.
Patients own their records.
Section 503: Administrative Reduction Target
Reduce administrative spending from roughly 25–30% of healthcare expenditures to below 10%.
Title VI: Supplemental Private Insurance
Private insurance remains legal for:
Private hospital rooms
Elective upgrades
Luxury amenities
Non-covered services
Similar to systems in Canada and several European countries.
The Transition Pathway
This is where most proposals fail.
The best transition is probably 10 years, not 2 years.
Phase 1 (Years 1–2)
Transparency Before Single Payer
Pass many of the reforms Mark Cuban advocates.
Requirements
Full price transparency
PBM reform
Drug rebate elimination
Interoperable records
Direct contracting options
National healthcare database
The purpose:
Understand actual healthcare costs.
Today nobody knows the true price of healthcare.
Phase 2 (Years 2–4)
Medicare Buy-In
Anyone can purchase Medicare.
Any age.
Any employer.
Any state.
Medicare becomes a public option.
People choose voluntarily.
Employer Option
Employers may:
Keep private insurance
Move employees into Medicare
Many firms switch because costs fall.
This creates market pressure without coercion.
Phase 3 (Years 4–6)
Lower Medicare Eligibility Age
Age drops:
65 → 60 → 55 → 50
Millions enter the public system gradually.
Insurance disruption remains manageable.
Medicaid Integration
Medicaid gradually merged into Medicare.
State administration simplified.
Federal standards become uniform.
Phase 4 (Years 6–8)
Universal Public Coverage
Every American automatically receives:
Hospital coverage
Physician coverage
Prescription coverage
Private insurance becomes supplemental.
At this stage most people are already using the public system.
Phase 5 (Years 8–10)
Full Single Payer
Private insurers cease offering duplicate primary coverage.
They may still sell supplemental plans.
The American Health Trust becomes the sole payer.
Workforce Transition Plan
This is politically essential.
The insurance industry employs hundreds of thousands of people.
The bill should include:
Healthcare Workforce Adjustment Fund
Funding for:
Retraining
Placement services
Early retirement
Tuition assistance
for workers displaced from:
Insurance companies
Claims processing
Revenue cycle management
Billing administration
Hospital Transition Fund
Many hospitals currently survive through cross-subsidies and opaque reimbursement.
A five-year transition fund should protect:
Rural hospitals
Safety-net hospitals
Teaching hospitals
during the shift.
What the End State Looks Like
For patients:
Healthcare card
No networks
No deductibles
No insurance shopping
No medical bankruptcy
For doctors:
One payer
One billing system
Less paperwork
For employers:
No health-plan management
No annual negotiations
Lower labor costs
For government:
One national risk pool
Strong bargaining power
Better public health data
The most realistic path may actually begin with the Cuban-style reforms. Transparency, PBM reform, direct contracting, and open pricing would expose where costs are truly coming from. Once those savings are visible, a Medicare buy-in could expand organically. In that sense, a Cuban-style market reform bill and a single-payer bill are not necessarily competing visions. The former could serve as the bridge that makes the latter politically and economically achievable.
The Case Against Single-Payer Healthcare—and Why the Debate Is More Nuanced Than It Appears
Few public policy issues generate as much passionate disagreement as healthcare. Advocates of single-payer healthcare argue that healthcare is a human necessity and should be guaranteed to all citizens. Critics argue that government-run systems inevitably become inefficient, expensive, and restrictive. Both sides often present their arguments as obvious truths, but the reality is more complicated.
The debate is not between perfection and disaster. It is between different ways of organizing a healthcare system, each with strengths and weaknesses. To understand whether single-payer healthcare is a viable option for the United States, it is worth examining the primary criticisms leveled against it and evaluating how serious those concerns actually are.
Criticism #1: Taxes Would Skyrocket
The most common criticism is that single-payer healthcare would require enormous tax increases.
This criticism is factually correct, but often incomplete.
A single-payer system would indeed require higher taxes because the government would assume responsibility for paying healthcare bills that are currently paid by employers, private insurers, and households. However, the relevant question is not whether taxes rise. The relevant question is whether total healthcare spending rises.
Most Americans already pay for healthcare through multiple channels: payroll deductions, employer contributions, deductibles, copayments, coinsurance, and surprise bills. Employer-sponsored insurance is often described as a benefit, but economists generally view employer healthcare spending as part of employee compensation. In other words, workers ultimately pay for their health insurance through reduced wages.
Under a single-payer system, many of these private payments would disappear and be replaced by taxes. The government's share of healthcare spending would increase dramatically, but household spending on premiums and out-of-pocket costs would fall.
The real policy question is whether the new taxes would exceed the private costs they replace. International experience suggests that many countries achieve universal coverage while spending significantly less per person than the United States.
The criticism is therefore not that taxes would rise—they would. The debate is whether overall healthcare spending would fall enough to offset those tax increases.
Criticism #2: Waiting Times Would Become Unbearable
Opponents frequently point to long waiting lists in countries such as Canada and the United Kingdom.
This concern is not imaginary. Some single-payer systems do experience longer waits for non-emergency procedures, specialist consultations, and elective surgeries.
However, the issue is more nuanced than critics often suggest.
The United States already has waiting times. They simply take a different form. Millions of Americans delay care because they cannot afford it, lack insurance, cannot obtain prior authorization, or face large deductibles. A patient who waits six months for surgery because of financial barriers is still waiting, even if the healthcare system technically has immediate capacity.
The challenge for any universal system is balancing access and capacity. Countries that invest sufficiently in physician training, hospital infrastructure, and diagnostic equipment generally perform better on wait times than those that underinvest.
A well-designed American single-payer system would need to expand medical school slots, residency positions, nursing programs, and hospital capacity. Waiting times are not an inevitable consequence of single-payer financing; they are often the consequence of inadequate healthcare supply.
Criticism #3: Government Is Inefficient
Many critics argue that government agencies are less efficient than private companies and that healthcare would suffer under government management.
Government inefficiency is a legitimate concern. Bureaucracies can become slow, rigid, and difficult to reform.
However, healthcare markets are unusual. Healthcare consumers rarely have perfect information, emergencies limit comparison shopping, and insurance obscures prices. These characteristics make healthcare different from ordinary markets.
Furthermore, the current American system is hardly a model of efficiency. Hospitals employ armies of billing specialists to navigate thousands of insurance contracts, coding systems, reimbursement rules, and prior authorization requirements. Physicians spend enormous amounts of time on paperwork.
The question is not whether government bureaucracy exists. It is whether one large bureaucracy would be more efficient than hundreds of competing bureaucracies operating simultaneously.
Single-payer advocates argue that administrative simplification would reduce waste. Critics argue that government inefficiency would eventually offset those gains. Both concerns deserve serious consideration, but it is inaccurate to assume that the current system is free from bureaucracy.
Criticism #4: Innovation Would Collapse
Another common argument is that America leads the world in pharmaceutical and medical innovation because it allows higher profits.
There is some truth to this claim.
American consumers effectively subsidize much of the world's pharmaceutical research because drug prices in the United States are often much higher than those in other countries.
If a single-payer system aggressively reduced drug prices, pharmaceutical profits could decline. Reduced profits could potentially lead to reduced private research investment.
However, innovation does not occur solely because of private markets. Many foundational medical breakthroughs originated from publicly funded research through organizations such as the National Institutes of Health.
The challenge is designing a system that preserves incentives for innovation while preventing excessive pricing. Drug pricing reform does not necessarily require eliminating profitability. It requires determining how much profit society is willing to pay for future innovation.
Criticism #5: Doctors Would Earn Less and Leave the Profession
Many physicians worry that single-payer reimbursement rates would reduce incomes.
In some specialties, this concern is likely valid.
American physicians, particularly specialists, often earn more than their counterparts in other developed countries. A single-payer system would likely exert downward pressure on certain reimbursements.
However, physicians also face unusually high administrative burdens. Many doctors report spending substantial time dealing with insurers, prior authorizations, and billing requirements. Simplification could partially offset lower reimbursement rates through lower overhead costs and reduced administrative work.
The key policy challenge would be maintaining physician compensation at levels sufficient to attract talented individuals while eliminating unnecessary administrative complexity.
Criticism #6: Patients Would Lose Choice
Critics often argue that single-payer systems reduce consumer choice.
Whether this is true depends on what type of choice is being discussed.
Americans currently have significant choice among insurance plans but often face limited choice among providers due to network restrictions. A patient may technically have dozens of insurance options but still be unable to see a preferred physician because that physician is outside the network.
In many single-payer systems, patients have fewer insurance choices but broader provider access.
The debate is therefore not simply about choice versus no choice. It is about whether citizens value choice among insurers or choice among doctors.
Criticism #7: The Transition Would Be Too Disruptive
This may be the strongest criticism of all.
The United States healthcare system employs millions of people in insurance, claims processing, billing, benefits administration, and related industries. Employer-sponsored insurance covers roughly half the population. Hospitals and physician groups have built their operations around existing reimbursement structures.
A sudden transition could create enormous economic disruption.
This is why a gradual transition is likely superior to a rapid one. Expanding Medicare eligibility, creating voluntary public options, integrating Medicaid over time, and providing workforce retraining could reduce disruption while allowing institutions to adapt.
The strongest argument against single-payer is not that the destination is impossible. It is that the journey must be carefully managed.
Criticism #8: Healthcare Demand Would Explode
When healthcare becomes free at the point of service, more people seek care.
Critics argue that this creates unsustainable demand and strains the system.
This concern is real. Utilization would almost certainly increase, particularly among individuals who currently avoid care because of cost.
However, not all increased utilization is wasteful. Preventive care, early diagnosis, and chronic disease management often reduce expensive emergency interventions later.
The challenge is creating incentives that encourage appropriate care while discouraging unnecessary utilization. Every healthcare system faces this challenge regardless of financing structure.
Criticism #9: America Is Too Large and Diverse
Some critics argue that healthcare systems that work in smaller countries cannot be replicated in a nation of more than 300 million people.
Scale certainly creates complexity. The United States is geographically vast, demographically diverse, and politically decentralized.
Yet the federal government already administers large national programs including Medicare, Social Security, and the tax system. Complexity is a challenge, but not necessarily an insurmountable one.
The larger question is whether political institutions can sustain a national healthcare system over decades despite changing administrations and shifting priorities.
Conclusion
The debate over single-payer healthcare is often framed as a contest between compassion and capitalism, or between universal coverage and economic freedom. In reality, the discussion is much more practical.
The strongest criticisms of single-payer healthcare are not imaginary. Taxes would rise. Some reimbursement rates would fall. The transition would be difficult. Government inefficiency is a legitimate risk. Maintaining innovation would require careful policy design.
At the same time, many criticisms are often overstated. The current American healthcare system already suffers from bureaucracy, restricted access, delayed care, administrative waste, and financial barriers that are largely absent in other developed nations.
The central question is not whether single-payer healthcare would create problems. Every healthcare system creates problems. The real question is which set of problems Americans prefer to live with.
Healthcare systems are ultimately exercises in trade-offs. Single-payer healthcare promises universal access, simplified administration, and stronger bargaining power. Its critics warn of higher taxes, government control, and reduced flexibility. The policy challenge is not to find a perfect system. It is to design one whose imperfections are more tolerable than the imperfections of the status quo.
No comments:
Post a Comment